Medical Devices

Vascular Graft Market – Analysis, Trends And Forecasts, 2015 To 2022

The vascular graft market was worth about USD 1.9 billion in 2014. It is projected to reach around USD 3.6 billion by 2022. Cardiovascular diseases and technological advances in tissue engineered vascular grafts are its drivers. Rising healthcare costs and favorable insurance policies will also augment market growth.

Apart from the aforementioned diseases, the current lifestyle of junk food, alcohol & tobacco consumption, and substance abuse will boost the usage of vascular grafts from 2015 to 2022 (forecast phase). Genetic factors like diabetes would also increase their usage during the same phase. High EVAR (endovascular aneurysm repair) volumes are the key driver of the vascular graft market.

For Market Research Report on “Vascular Graft Market” Visit –

The market products are coronary artery by-pass grafts, endovascular stent grafts, hemodialysis access, and peripheral vascular. Among these, endovascular stent grafts accounted for over 85% of the market in 2014. Factors attributing to their share are current lifestyles and minimal physical activities.

The vascular graft market is also segmented on the basis of applications. These include diabetes, aneurysm, kidney failures, vascular occlusion, and cardiovascular diseases. Cardiovascular diseases accounted for 25% shares in 2014. This was credited to the high prevalence of blood sugar, hypertension, and age-related illnesses. Cardiovascular diseases result directly from coronary artery diseases, diabetes, and obesity.

On the basis of raw materials, the vascular graft market is divided into polyurethane, polyester, polytetrafluoroethylene, and biological materials. Polyester had 38% share in the past. Biological materials are sub-divided into human saphenous & umbilical veins and tissue engineered materials. They are preferred more on account of reduced post surgery complications. Biological materials are expected to be the fastest growing raw material in the forecast phase.

The vascular graft market is also split on the basis of regions. These are North America, Europe, Asia Pacific, Latin America, and Middle East & Africa (MEA). North America accounted for 50% share in 2014. This was attributed to collaborations between research organizations & manufacturers and advanced healthcare infrastructure. Asia Pacific should be the fastest growing region, with about 10% CAGR in the seven years ahead.

Research facilities and favorable governmental initiatives like ‘Make in India’ targeting cardiovascular diseases will favor this region. Major players of the global vascular graft market comprise Medtronic Plc., Terumo Medical Corporation, Bard Peripheral Vascular Inc., Junken Medical Co. Ltd., and Cook Medical.

Vascular Graft Market

Information Source: Grand View Research

Medical Devices

U.S. Medical Device Outsourcing Market – Analysis, Trends And Forecasts, 2015 To 2022

The U.S. medical device outsourcing market generated around USD 13.3 billion in 2014. The major market driver is demand for healthcare instruments & cost control. Additionally, connected advantages like decreased production costs and concentration on core proficiencies are predicted to boost the market in the forecast period (2015 to 2022).

The geriatric populace is susceptible to chronic illnesses and also drives the market. Complications in product manufacturing and growing small-sized manufacturers provide future prospects to this market. However, the market faces hindrances from drastic reductions in U.S. public investments.

For Market Research Report on “U.S. Medical Device Outsourcing Market” Visit –

Moreover, productivity pressure, escalating costs & competition, and higher market penetration have impacted the U.S. medical device outsourcing market. Wide prevalence of traumatic wounds, cardiac illnesses, and cancers enhance the demand for surgical practices. This causes growth in surgical equipment and propels market incomes.

The market is bifurcated into applications and services. Class II, class III, and class I are the application segments. Class II devices captured around 48% shares in 2014. They should notice the fastest expansion (at about 9.8% CAGR) in the coming seven years. These equipment decrease the dangers of death & injuries.

Class II devices include surgical drapes, powered wheelchairs, infusion pumps, and others. Easier technologies in comparison to class III devices turn class II devices into the most outsourced. In regards to services, the U.S. medical device outsourcing market was led by product development & design in 2014. This segment held more than 25 % shares that year.

It is the most capital extensive industrialized segment and will experience maximum outsourcing rates. Regulatory services occupied the second biggest share in 2014. They are highly popular and broadly recognized. Product implementation services are anticipated to grow lucratively (at more than 11 % CAGR) during the forecast period.

Use of process overlapping as a beneficial alternative and synchronized product design implementations are the reasons for their fast growth. Some key players in the U.S. medical device outsourcing market comprise Accellent Inc., Kinetics Climax, Avail Medical Products Inc., Active Implants Corporation LLC, and Teleflex Medical OEM.

They offer cost-effective equipment & services to recipient establishments. The players also indulge in mergers and acquisitions for market penetration.

U.S. Medical Device Outsourcing Market

Information Source: Grand View Research

Medical Devices

North America Home Healthcare Market – Analysis, Trends And Forecasts, 2015 To 2022

The North America home healthcare market was worth USD 757 million in 2014. It is projected to grow lucratively, at around 10% CAGR during 2015 to 2022 (forecast period). This can be attributed to geriatrics population and resulting chronic ailments. Increasing need to lower the healthcare costs is another market driver.

Chronic ailments require continuous care & attendance. Hospitalization involves huge costs. Demand for hospital beds outnumbers their supply. Home healthcare is an effective & affordable solution to these problems.

For Market Research Report on “North America Home Healthcare Market” Visit –

Coverage under Medicaid, Medicare, and other private insurance providers is also an advantage. Moreover, governmental initiatives (e.g. Canadian Home Care Association) will encourage home healthcare. The North America home healthcare market is categorized into products, services, and countries.

Product segments are wound care, heel protectors, mattress overlays, and seating cushions. Wound care is sub-divided into wound care products, wound closure products, wound cleaners, lotions & creams, and wound care dressings.

Heel protectors are split into cushions, gels, silicon sleeves, convoluted foam boots, and synthetic protective boots. Mattress overlays comprise low air loss mattresses, pressure relief & alternating pressure mattresses, memory foam mattresses, and premium guard water mattresses. Seating cushions include latex cushions and gel & form cushions.

Wound care held over 64% of the total revenues in 2014. Infected wounds are a major concern, significantly furthering this product. Mattress overlays could capture major shares by 2022. Wound care and mattress overlays are jointly estimated to capture 86% shares by the same year. Diabetic ulcers, pressure ulcers, and venous stasis ulcers should contribute to this large share.

Services are split into home care, unskilled home care, durable medical equipment, and others. Home care services, with 31% revenues, were the leading segment in 2014. Durable medical equipment could occupy about 26% shares by 2022.

On the basis of countries, the market is categorized into U.S., Mexico, and Canada. The U.S. would grab lion’s share (over 86%) by the end of the forecast period. Sophisticated healthcare, high disposable earnings, patient awareness, and geriatric populace will be the key drivers of this country. Leading players of the North America home healthcare market comprise Span America, Smith & Nephew, Invacare, and Kinetic Concepts.

North America Home Healthcare Market

Information Source: Grand View Research

Medical Devices

Hemostasis And Tissue Sealing Agents Market – Analysis, Trends And Forecasts, 2015 To 2022

The hemostasis and tissue sealing agents market was about USD 3.4 billion in 2014. Hemostats & sealants are healthcare instruments that stop hemorrhages & bleeding. These conditions may arise from surgical practices & wounds. The market is predicted to experience profits from 2015 to 2022 (forecast period). This would result from increasing surgery volumes globally.

Major companies adopt strategies to increase their shares. This also propels market revenues. Similarly, geriatric population & chronic diseases promote market sales. These devices offer several benefits & are patient-friendly. This factor is also projected to assist the hemostasis and tissue sealing agents market.

For Market Research Report on “Hemostasis And Tissue Sealing Agents Market” Visit –

Diabetes, hernia fixation, eye & spinal injuries, burns, and urological disorders are some of the chronic conditions needing hemostats & sealants. Urological surgeries involving minimal invasiveness specifically utilize hemostatic solutions, furthering the market. Maximum demand for these products stems from general surgeries & cardiac illnesses.

Wide usage of these devices in cardiac diseases is credited to improved medical results. The hemostasis and tissue sealing agents market is bifurcated into products and regions. Products include tissue sealants and topical hemostats. Topical hemostats are divided into active, mechanical, and flowable. Sealants & adhesives take care of blood loss during surgical practices.

The regional segments comprise North America, Asia Pacific, Europe, and rest of the world.  North America occupied the biggest share due to cancer, diabetes, and cardiac incidences in the region. Other regional drivers consist of product launches, aggressive sales of these devices, and use of these products in medical procedures. Asia Pacific should be lucrative owing to its surgical practices & healthcare tourism. It is likely to gain more than 25% share by the end of the forecast period.

Europe would be propelled by regional surgeries & elderly population. Some of the primary companies affiliated with the global hemostasis and tissue sealing agents market encompass CryoLife, Advance Medical Solutions Group, C.R. Bard, and B. Braun. Strategic measures adopted by these players comprise integration of bacteriostatic features, research in formulation expansion, and connections with medical centers & hospitals.

Another key strategy followed by them includes mergers & acquisitions to ensure market presence and sustainability.

Hemostasis And Tissue Sealing Agents Market

Information Source: Grand View Research

Medical Devices

Diabetic Retinopathy Market – Outlook, Trends AndPredictions, 2015 To 2022

Diabetic retinopathy refers to an eye disorder that injures the retina’s blood vessels. The light-sensitive interior eye surface on which images are produced is known as the retina. Diabetes can impact the retina in the long run. This is owing to high levels of blood glucose injuring the retina’s small blood vessels. The management of diabetic retinopathy relies on the phase of the illness. It is led forward to hinder or prevent the disease from advancing further. Anti-VEGF drugs, laser surgery and vitrectomy are some of the treatments available.

For Market Research Report on “Diabetic Retinopathy Market” Visit –


Rising diabetes cases around the world are expected to steer further demand for the diabetic retinopathy market. The worldwide market was predicted to have collected an income worth around 5, 934 million in 2014. It is projected to rise at about 6.8 percent CAGR through the forecast phase. Growing blindness cases triggered by diabetes also further the market.

The diabetic retinopathy market includes screening of the retina and choice of treatment based on how severe the condition is.Moreover, augmenting population of the elderly is also estimated to improve the applicability of the market, thus propelling the same. Financialsustainability on account of 11 percent worldwide medical expenses in the management and prevention of this illness is a primary driver for emergent regions to endorse the diabetic retinopathy market.


The various categories into which the diabetic retinopathy market is divided are treatments, kinds and geographies. The treatments market consists of intraocular steroid injections, anti-VEGF treatment, vitrectomy and laser surgery.

The market, on account of kinds, is segmented into non-proliferative diabetic retinopathy and proliferative diabetic retinopathy. The geographies diabetic retinopathy market is fragmented on the basis of Europe, rest of the world, North America and Asia Pacific.


The treatments diabetic retinopathy market is likely to be dominated by the anti-VEGF sector. This sector is predicted to occupy the biggest share through the forecast phase. This is due to connected attributes, such as quicker recuperation and improved treatment. The kinds diabetic retinopathy market was dominated by the sector of non-proliferative diabetic retinopathy in 2014. This sector made up for the biggest share. This was on account of several patients within an illness history of less than ten years.

Growing diabetes cases, non-compliant screening of retina and falling short of exact detection are the drivers of the non-proliferative diabetic retinopathymarket sector. Proliferative diabetic retinopathy is estimated to experience profitable expansion in the future.This expansion is expected owing to the rising population of old people entering the proliferative phase of retinopathy. The geographies diabetic retinopathy market was leaded by North America in 2014. The region occupied the biggest share.

This was due to increasing diabetes cases, rising demand for the untimely diagnosis of diabetic retinopathy and favorable reimbursement amenities. Huge infiltration of anti-VEGF drugs in markets is a prime factor adding revenue to this region. The Europeandiabetic retinopathy market followed North America and produced the second biggest income. It was propelled forward by amplified consciousness among patients. The developing countries of Asia Pacific are anticipated to undergo significant expansion through the forecast phase.

This is because of the intensifying old population, growing disposable incomes and boosting research subsidies for diabetes.

Diabetic Retinopathy Market

Information Source: Grand View Research

Medical Devices

Contraceptives Market – Size, Outlook, Sectors And Trends, 2015 To 2022

The worldwide contraceptives market was estimated at about USD 15.7 billion in 2013. It is anticipated to attain around USD 19.6 billion by 2020. The market is predicted to record a CAGR of around 3.1 percent during 2014 to 2020.  Contraceptives refer to devices and drugs which help avoid pregnancies and also protect from sexually transmitted illnesses. Governmental initiatives to take care of population growth and endorse safer sex are the two main elements driving the contraceptives market further.

For Market Research Report on “Contraceptives Market ” Visit –

Also, different consciousness initiatives by participants of the market are another prime factor, driving further growth of contraceptives. The market is projected to rise profitably through the forecast phase. This is on account of increased demand for population control and rising sexually transmitted diseases. Additionally, enforcement of initiatives intended at curtailing medical expenses connected with unplanned pregnancies and consequent increasing consciousness levels are also anticipated to drive the contraceptives market ahead.


The worldwide contraceptives market is segmented on the basis of two sectors. These include products and geographical regions. The products market consists of drugs and devices. Drugs contain injectables, topical contraceptives and oral contraceptive pills.

Devices encompass female condoms, male condoms, vaginal rings, sub-dermal implants, intrauterine devices, diaphragms, and non surgical permanent contraception devices.

On a geographical basis, the contraceptives market is fragmented on account of Asia Pacific, Europe, rest of the world and North America.


Devices occupied the biggest share in the products market in 2013. They accounted for nearly 60 percent of the entire contraceptives market that year. The lucrativeness of this sector is credited to wide acceptance of male and female condoms, copper IUDs and sino implants. Condoms are great means of preventing unwanted pregnancies and HIV infections. This factor propels their use in men. Also, augmented consciousness regarding sexually transmitted diseases increases the use of contraceptive devices.

Subdermal implants possess massive prospectives to meet the demands of women in family planning. The IUD segment occupied one of the biggest shares in the products devices contraceptives market in 2014. This was due to escalated demand for these devices in Asia Pacific and Europe. Amplified gynecologists choosing such devices for their patients are also a major factor, driving this segment forward during the forecast phase.

Out of the four regions in the worldwide contraceptives market, North America occupied the biggest share in 2014. The region accounted for more than 30 percent share. This was because of growing abortion cases, augmented women population in the age group of 15-44 years and high patient consciousness in the region. The European contraceptives market also occupies a major share. This share is with respect to subdermal implants and IUDs.

The Latin American contraceptives market is anticipated to rise quickly in the coming years. This is owing to huge unexplored prospects and continually improving medical infrastructure. Rising patient consciousness and fiscal growth are also responsible for enhancing the status of the Latin American market. Supportive governmental initiatives in relation to sex education are a vital success component, expanding the contraceptives market further during the coming years.

Contraceptives Market 

Information Source: Grand View Research

Medical Devices

Transcatheter Embolization and Occlusion Devices Market Analysis by Type of Product, by indication and Segment Forecasts to 2022

The global demand of transcatheter embolization and occlusion devices is anticipated to boost during the forecast period. Rising geriatric population base, increasing incidences of cancer, intracranial aneurysm and cardiovascular diseases and elevated preference of patients towards non-surgical procedures are high impact rendering drivers of the market. Innovation and new product development to assist non-surgical procedures along with growing support from government for increasing awareness level further drive the transcatheter embolization and occlusion devices market. Favorable government support for funding and reimbursement, such as in liver cancer patients by the UK government, further boosts the market growth.

For Market Research Report on “Transcatheter Embolization and Occlusion Devices Market” Visit –

Transcatheter embolization and occlusion devices market is segmented into interventional neuro-radiology and peripheral vascular (PV) tumors according to indication. The PV tumors segment held the largest share in 2014 owing to rising occurrences of the disease. In terms of product segmentation, PV embolization coil held the largest share of the transcatheter embolization and occlusion devices market. However, the introduction of liquid embolics and flow diverting devices are expected to affect the share during the next seven years. Flow diverting devices are tested to be more effective in treatment of wide neck aneurysms over embolization coils.

North America market held the largest share in this market in 2014 due to technological advancement and rising healthcare spending. Europe follows America in terms of revenue for the transcatheter embolization and occlusion devices market. Growth in both the regions is due to rising population of geriatrics and patients showing promising therapeutic actions in clinical trials. Another chief driver is the continuous evolution in designs of the systems and product to meet the needs of the patient. Germany held the highest share in the European market owing to presence of many manufacturing units within the region. European transcatheter embolization and occlusion devices market is expected to boost during the forecast period due to high quality, environment friendly product manufacturing processes indicated by CE markings. APAC region is anticipated to be the fastest growing region particularly, China, India and South Korea. The inducers of this growth are increasing chronically ill patient population with cardiovascular and liver diseases and improved product portfolio.

Key market players of the transcatheter embolization and occlusion devices market include Covidien, Direct Flow Medical Inc. Boston Scientific Corporation, Cordis Corporation, Abbott Laboratories Inc., St. Jude Medical, Cook Medical, Pfizer, Lombard Medical, Mallinckrodt LLC, MicroPort Medical, Eisai Co. Ltd., JenaValve, , CeloNova BioSciences, Medtronic Inc., Jotec gmbh, Edward LifeSciences, Sirtex medical, Terumo Corporation Inc., Merit Medical Systems, DePuy Synthes, Transcatheter Technologies, Marine Polymer Technologies Inc., Nrodion, Symetis and eV3 Inc. Newer products are expected to be launched during the forecast period which have attained FDA approval such as  Aorfix Flexible Stent Grafting System. These technologically advanced devices and systems are anticipated to further fuel the growth of the transcatheter embolization and occlusion devices market.

Transcatheter Embolization and Occlusion Devices Market

Information Source: Grand View Research

Medical Devices

Laparotomy Sponge Market Analysis by Type (Sterile and Non Sterile) Medical Procedures (Non Washed and Pre Washed) Analysis, Regional Outlook, Competitive Strategies and Forecasts, 2015 To 2022

Global laparotomy sponge market is expected to witness remarkable growth over the coming seven years due to increasing technological advancements in this sector. In addition, growing prevalence of abdominal diseases such as colon cancer is further anticipated to propel the market growth for laparotomy sponges in near future. According to a data published by the ACS (American Cancer Society), around 96,830 patients are diagnosed with colon cancer every year which is expected to drive the market demand for laparotomy devices. Furthermore, rising geriatric population base is also anticipated to accentuate the market growth owing to the fact that old aged people are more prone to abdominal diseases that requires laparotomy.

For Market Research Report on “Laparotomy Sponge Market” Visit –

The global laparotomy sponge market is categorized on the basis of types and medical procedures. By types, the market is bifurcated into sterile laparotomy sponge and non sterile laparotomy sponge. Sterile laparotomy sponge market is anticipated to register fastest market growth over the forecast period due to enhanced safety from infective agents. By medical procedures, the market for pre washed laparotomy sponge is expected to gain higher market share owing to growing utilization in extensive laparotomy surgeries. Regionally, as of 2014, North America held the largest growth share due to growing prevalence of colon cancer and usage of technically advanced laparotomy techniques. Similarly, European region is anticipated to register substantial market growth owing to increasing geriatric population base with abdominal diseases. Increasing healthcare investments and personal disposable income are the factors responsible for providing fastest growth to Asia pacific region. Also, Latin American countries are expected to witness rapid growth over the coming seven years owing to rising awareness about advanced laparotomy devices and healthcare infrastructure.

The key companies operational in laparotomy sponge market are Guangda Textile, Derma Sciences Inc., Medline Industries Inc., SurgiCount Medical, Actimed, Medical Action Industries Inc., Smith and Nephew, Premier Enterprises and Kendall Healthcare. The market players are adopting competitive strategic measures such as new product development, collaborations and R&D operations in an attempt to increase their market share. For example, in 2013, SurgiCount Medical introduced a SAFE-T Lapsponge, an innovative product designed to assist the user of Safety Sponge System with an added advantage of safety and ease of use. The Lapsponge is clinically proven to reduce occurrence of miscounted & misplaced sponge and remove retained surgical sponge. The laparotomy sponges market is anticipated to register further market growth as the companies are striving to market their products online and improve their promotional activities.

Laparotomy Sponge Market

Information Source: Grand View Research

Medical Devices

Therapeutic Respiratory Devices Market By Product (Nebulizers, Humidifiers, Oxygen Concentrators, Positive Airway Pressure Devices, Ventilators, Capnographs, Gas Analyzers) Analysis, Regional Outlook, Competitive Strategies and Forecasts, 2015 to 2022

The global therapeutic respiratory devices market is expected to witness lucrative growth over the forecast period as a consequence of rising incidences of respiratory diseases such as tuberculosis, asthma and other respiratory allergies. Global rising inclination towards home healthcare institutions is high impact rendering driver of this market. Introduction of novel features such as dose tracking and breath actuation are further expected to provide a growth platform to the therapeutic respiratory devices market.

For Market Research Report on “Therapeutic Respiratory Devices Market” Visit –

The market is segregated on the basis of product into nebulizers, ventilators, oxygen concentrators, capnographs, positive airway pressure devices, humidifiers, and gas analyzers. Nebulizers are segmented into compressor based, ultrasonic and piston based hand held nebulizer. Humidifiers are segregated into heated, stand-alone, integrated, passover and built-in. Oxygen concentrators are divided into fixed oxygen concentrators and portable concentrators. Positive airway pressure devices are categorized into continuous, bi-level and auto-titrating devices. As of 2014, positive airway pressure devices dominated the therapeutics respiratory devices market due to rapid technological innovations. Nebulizers are anticipated to be the fastest growing segment of the market as a consequence of overcoming limitations associated with traditional alternatives.

As of 2014, North America held substantial share as a consequence of growth factors including rising prevalence of respiratory disorders. Increasing geriatric patient base, lifestyle associated changes and high disposable income are also key growth factors for this region. Asia Pacific region is anticipated to be the fastest growing owing to rising disposable income and increasing patient awareness.

Major players of therapeutics respiratory devices market include CareFusion Corporation, Airsep Corporation, Compumedics Ltd., Covidien PLC, Fisher & Paykel, Merck & Co. and Respironics, Inc, GE Healthcare, Smiths Medicals, Philips Healthcare, Invacare and Boehringer Ingelheim. These players focus on developing recent technologies in order to expand their market share. These players also employ extensive marketing and sales strategies, targeting regions, and mergers & acquisitions in order to expand their market share. For instance, in 2015, Compumedics entered into distribution contract with Bestmed in order to enhance its position as sleep diagnostic products distributor in the market. Also, in 2015, GE Healthcare and Sanford Health announced service agreement in order to expand the healthcare capabilities thereby capitalizing their market share. Presence of high competition, high R&D investments and rising patent approvals by these companies is expected to expand their market share over the forecast period.

Therapeutic Respiratory Devices Market

Information Source: Grand View Research